Cellular Uptake and Cytotoxicity of Drug–Peptide Conjugates Regulated by Conjugation Site
Citations Over TimeTop 10% of 2013 papers
Abstract
Conjugation of anticancer drugs to hydrophilic peptides such as Tat is a widely adopted strategy to improve the drug's solubility, cellular uptake, and potency against cancerous cells. Here we report that attachment of an anticancer drug doxorubicin to the N- or C-terminal of the Tat peptide can have a significant impact on their cellular uptake and cytotoxicity against both drug-sensitive and drug-resistant cancer cells. We observed higher cellular uptake by both cell lines for C-terminal conjugate relative to the N-terminal analogue. Our results reveal that the C-terminal conjugate partially overcame the multidrug resistance of cervical cancer cells, while the N-terminal conjugate showed no significant improvement in cytotoxicity when compared with free doxorubicin. We also found that both N- and C-conjugates offer a mechanism to circumvent drug efflux associated with multidrug resistance.
Related Papers
- → The role of RND-type efflux pumps in multidrug-resistant mutants of Klebsiella pneumoniae(2020)77 cited
- → Antimicrobial Resistance: Two-Component Regulatory Systems and Multidrug Efflux Pumps(2023)71 cited
- → A genetic platform to investigate the functions of bacterial drug efflux pumps(2022)45 cited
- Progress on Escherichia coli AcrAB-TolC Multidrug Efflux Pump and Its Regulation(2008)